Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Nutra Pharma Corp. (NPHC) had Revenue of $0.10M for the most recently reported fiscal year, ending 2021-12-31.

Quarterly Annual

Figures for fiscal year ending 2021-12-31

Income Statement Financials
Revenue	$0.10M
Net Income	$-13.10M
Cost of Goods Sold	$0.09M
Gross Profit	$0.01M
Operating Expenses	$2.09M
Operating Income	$-1.99M
Non-Operating Income/Expense	$-11.11M
Pre-Tax Income	$-13.10M
Normalized Pre-Tax Income	$-13.10M
Income after Taxes	$-13.10M
Income from Continuous Operations	$-13.10M
Consolidated Net Income/Loss	$-13.10M
Normalized Income after Taxes	$-13.10M
EBIT	$-1.99M
EBITDA	$-1.61M
Weighted-Average Shares Outstanding (Basic)	7.23B
Weighted-Average Shares Outstanding (Diluted)	7.23B
Earnings per Share (EPS) (Basic)	$0.00
Earnings per Share (EPS) (Diluted)	$0.00
Balance Sheet Financials
Current Assets	$0.53M
Property, Plant, and Equipment	$0.04M
Long-Term Assets	$0.25M
Total Assets	$0.78M
Current Liabilities	$21.14M
Long-Term Debt	$0.52M
Long-Term Liabilities	$0.52M
Total Liabilities	$21.66M
Common Equity	$-20.89M
Tangible Shareholders Equity	$-20.88M
Shareholders Equity	$-20.88M
Common Shares Outstanding	7.33B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-1.74M
Cash Flow from Investing Activities	$-0.29M
Cash Flow from Financial Activities	$2.13M
Beginning Cash	--
End Cash	$0.09M
Increase/Decrease in Cash	$0.09M
Stock-Based Compensation	$0.15M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.03
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-0.03
Debt to Equity Ratio	-0.39
Gross Margin	8.66%
Operating Margin	-2034.53%
EBIT Margin	-2034.53%
EBITDA Margin	-1649.00%
Pre-Tax Profit Margin	-13399.01%
Profit Margin	-13399.01%
Free Cash Flow	$-1.78M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.13
Inventory Turnover	2.85
Receiveable Turnover	0.30
Days Sales in Receivables	1215.53
Return on Equity	62.69%
Return on Tangible Equity	62.73%
Return on Assets	-1678.87%
Return on Investments	64.32%
Book Value Per Share	$-0.00
Free Cash Flow per Share	$-0.00
Operating Cash Flow per Share	$-0.00

Data from Zacks Investment Research, Inc.